The therapeutic potential of CRISPR/Cas genome editing has advanced the development of precision medicine; however, its clinical translation for many in vivo applications remains limited by challenges in achieving safe, efficient, and targeted delivery. Conventional viral vectors and synthetic nanocarriers are associat...
Ayesha Zahid, Hazrat Ismail, A. Qadeer et al.· Journal of drug targeting (P...· 0 citations
ABSTRACT Viral diseases remain a major global health challenge despite substantial advances in vaccination, antiviral therapeutics, and public‐health interventions. However, current antiviral strategies are still constrained by important gaps, including rapid viral evolution, limited broad‐spectrum efficacy, immune esc...
Sawar Khan, A. Nisar, Xiao-Xu Li et al.· MedComm· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.